Aug 6, 2008 by Brian Orelli, PhDOnyx in the Black -- for NowPositive earnings, but losses may be ahead.
Aug 5, 2008 by Brian Orelli, PhDNo Slowdown for China MedicalFools like to see growth in sales of high-margin products.
Aug 1, 2008 by Brian Orelli, PhDTargeted Medicine: Health Care's Next Big Thing Tailoring drugs to smaller groups looks like the wave of the future.
Aug 1, 2008 by Brian Orelli, PhDRecession Schmession, This Industry Is On FirePharma is cutting costs and this industry is only too happy to help.
Aug 1, 2008 by Brian Orelli, PhDHansen's HamperedFlat quarter-over-quarter system sales isn't going to get it done.
Jul 30, 2008 by Brian Orelli, PhD5 Health Care Companies Flying Below the RadarThey've all got a potentially winning story.
Jul 30, 2008 by Brian Orelli, PhDTeva Has Revenue in All the Wrong PlacesSometimes double-digit growth isn't all it's cracked up to be.
Jul 28, 2008 by Brian Orelli, PhDCoventry Covets 2007Revenue is headed in the right direction, but income isn't.
Jul 25, 2008 by Brian Orelli, PhDGeneric Heartburn at WyethThe drugmaker takes charges to get leaner.
Jul 24, 2008 by Brian Orelli, PhDIllumina Polishes Its BiochipsWho's going to complain about double-digit growth?
Jul 24, 2008 by Brian Orelli, PhDIntuitive Surgical's Still on SaleDespite the price jump, it's not that much more expensive.
Jul 24, 2008 by Brian Orelli, PhDUnitedHealth Looking HealthierThe insurance giant beats its lowered earnings.
Jul 23, 2008 by Brian Orelli, PhDLeaner Boston Scientific Isn't Looking HealthyIt lost some fat, but now it needs to build some muscle.
Jul 22, 2008 by Brian Orelli, PhDAnemic Amylin's Signs of RecoveryThe growth of its main drug is headed in the right direction.
Jul 22, 2008 by Brian Orelli, PhDDrug Duo SEAS Disappointment -- AgainMerck and Schering continue their string of bad luck.
Jul 22, 2008 by Brian Orelli, PhDThe Growth Doctor Is InDr. Reddy's grows the top line, but it still has some work to do.
Jul 18, 2008 by Brian Orelli, PhDSt. Jude Is a FighterThe medical device maker continues to kick the competition while it's down.
